Danaher to Present at J.P. Morgan Healthcare Conference

06.01.25 22:15 Uhr

Werte in diesem Artikel
Aktien

231,50 EUR 4,70 EUR 2,07%

WASHINGTON, Jan. 6, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 14, 2025 at 11:15 a.m. PT. The event will be simultaneously webcast and can be accessed on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations."

ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.

Cision View original content:https://www.prnewswire.com/news-releases/danaher-to-present-at-jp-morgan-healthcare-conference-302343009.html

SOURCE Danaher Corporation

Ausgewählte Hebelprodukte auf Danaher

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Danaher

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Danaher Corp.

Wer­bung

Analysen zu Danaher Corp.

DatumRatingAnalyst
19.07.2019Danaher BuyNeedham & Company, LLC
30.05.2019Danaher OutperformWolfe Research
17.04.2019Danaher BuyNeedham & Company, LLC
28.02.2019Danaher BuyNeedham & Company, LLC
03.01.2019Danaher BuyNeedham & Company, LLC
DatumRatingAnalyst
19.07.2019Danaher BuyNeedham & Company, LLC
30.05.2019Danaher OutperformWolfe Research
17.04.2019Danaher BuyNeedham & Company, LLC
28.02.2019Danaher BuyNeedham & Company, LLC
03.01.2019Danaher BuyNeedham & Company, LLC
DatumRatingAnalyst
21.04.2017Danaher Sector PerformRBC Capital Markets
27.05.2016Danaher Sector PerformRBC Capital Markets
22.04.2016Danaher Sector PerformRBC Capital Markets
27.01.2016Danaher Sector PerformRBC Capital Markets
23.10.2015Danaher Sector PerformRBC Capital Markets
DatumRatingAnalyst
14.12.2006Danaher underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Danaher Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"